Bio Briefs
Posted By
Recent Posts on This Topic | See All >
-
Feb 07, 2012 Support grows for medical-device community -
Dec 19, 2011 BioAccel launches network to attract bio funding
-
Jul 19, 2011 Cardinal Health opens $11M Phoenix facility
-
Apr 07, 2011 Algae Biosciences Corp. taken public
Share on Twitter
Share on Facebook
Email to a friend
Print Article
Small business grant will help develop Valley Fever drug here
[Source: KVOA.com] - A small business grant will help an Arizona-based company develop a drug for Valley Fever.
Valley Fever Solutions Inc (VFS) has been awarded $3 million from the National Institutes for Health (NIH) to continue the commercialization of nikkomycin Z (NikZ), a potentially curative therapy for Valley Fever.
Starting this week, the funds will be administered over the next three-years by the National Center for Minority Health and Health Disparities, one of the institutes and centers of the NIH.
For more information: Small business grant will help develop Valley Fever drug here
Quick Links
- NEW: About the Arizona Center for Civic Leadership
- Arizona Biosciences News
- Arizona BioMap
- Roadmap Progress Updates
- Reports & Multimedia
- Timeline: Arizona's Bio Growth
- Arizona Bio Orgs on Twitter
- Arizona BioBasics
- The Biozona Brand
- Newsletter Signup
Download a new brochure from the Flinn Foundation outlining the 2011 progress on Arizona's Bioscienced Roadmap: a record high in bioscience jobs, plus gains in firms and venture-capital funding. Numerous achievements during the year advanced the core strategies of the Roadmap.
Also, read the full Performance Assessment describing in detail Arizona's 2011 progress on key Roadmap metrics.
